The rate of HER2 positivity in BTC (biliary tract cancers) has been reported to be 5–20% and between 5–50% for PDAC (pancreatic ductal adenocarcinoma). This evidence concerns the gene ERBB2 and pancreatic ductal adenocarcinoma.